1. Regulatory Frameworks and Compliance Obligations
Federal and state regulations create a layered compliance environment for acquisitions. Securities law, antitrust statutes, and state corporate law each impose distinct procedural and substantive requirements. From a practitioner's perspective, the regulatory landscape often determines the deal timeline and cost structure more than the commercial negotiations do.
The Hart-Scott-Rodino Antitrust Improvements Act imposes filing obligations when transaction size meets statutory thresholds, triggering federal review periods that can extend deal closure by months. State-level corporate statutes govern shareholder approval processes, appraisal rights, and director fiduciary duties during sale negotiations. Securities law compliance requires disclosure of material facts to shareholders and, in some cases, to the SEC, with liability exposure for omissions or misstatements that affect investor decisions.
Federal Antitrust and Hart-Scott-Rodino Requirements
The Hart-Scott-Rodino Act requires parties to file with the Federal Trade Commission and Department of Justice when an acquisition meets size-of-transaction thresholds, currently adjusted annually for inflation. The initial review period is 30 days; if regulators issue a Second Request for additional information, the review period extends, often by several months. Parties cannot close the transaction until the waiting period expires or regulators grant early termination.
Antitrust analysis focuses on market concentration, barriers to entry, and competitive effects in defined product and geographic markets. Regulators may condition approval on divestitures, behavioral remedies, or structural changes to the combined entity. Understanding the competitive landscape early in deal planning allows counsel to identify potential antitrust exposure and design transaction structure to mitigate regulatory risk.
State Corporate Law and Fiduciary Duties
Under New York Business Corporation Law and similar state regimes, directors owe fiduciary duties to the corporation and shareholders when a sale is being considered. These duties require directors to act in good faith, seek fair value, and avoid conflicts of interest. Courts in New York and Delaware have developed substantial case law on what constitutes adequate process in sale transactions, including the scope of board investigation, the role of special committees, and the weight given to shareholder votes.
In practice, these disputes rarely map neatly onto a single rule. Courts evaluate the totality of circumstances, including whether the board engaged financial advisors, sought multiple bids, and allowed adequate time for due diligence. Boards that document their process contemporaneously and engage independent advisors create a stronger record if shareholders later challenge the transaction.
2. Representations, Warranties, and Post-Closing Risk Allocation
Representations and warranties are contractual statements about the target company's condition, operations, and legal compliance. These provisions serve as the primary mechanism for post-closing dispute resolution and risk allocation between buyer and seller. The scope, breadth, and survival periods of representations directly affect the buyer's remedies if undisclosed liabilities or inaccuracies emerge after closing.
Buyers typically seek broad representations covering financial statements, litigation, regulatory compliance, and material contracts. Sellers resist broad language and push for knowledge qualifiers, materiality thresholds, and shorter survival periods. The negotiation of these provisions often consumes substantial deal time and reflects the parties' relative bargaining power and risk tolerance.
Indemnification Baskets, Caps, and Survival Periods
Indemnification provisions establish how the parties will resolve post-closing disputes over breached representations. A typical structure includes a deductible (basket), a maximum recovery cap, and a survival period beyond which claims cannot be brought. Baskets are often set at 0.1 to 0.5 percent of purchase price; caps typically range from 10 to 50 percent of the purchase price, or are set at a fixed dollar amount negotiated between the parties.
Survival periods vary by representation type. Core representations (title, authority, capitalization) often survive for 18 to 24 months or longer. Tax and environmental representations may survive longer due to the extended periods for regulatory review and claims. Short survival periods limit the buyer's window to investigate and bring claims, while long periods create uncertainty for the seller.
Disclosure Schedules and Exceptions
Disclosure schedules are attachments to the purchase agreement that list exceptions to the representations. A representation may state that the target has no undisclosed liabilities, with an exception for items disclosed on Schedule 3.18. The scope and detail of disclosure schedules directly affect whether a buyer can later claim indemnification for known or disclosed risks.
Courts in New York and nationally have addressed disputes over whether disclosed items fall within the scope of exceptions or whether ambiguous language in schedules favors the buyer or seller. Precise drafting of schedules, cross-referencing to supporting documents, and clear categorization of exceptions reduce post-closing disputes.
3. Due Diligence and Information Risk Management
Due diligence is the buyer's investigation of the target company's financial condition, operations, contracts, litigation, and regulatory compliance. The scope and rigor of due diligence directly affect the buyer's ability to negotiate indemnification and to succeed in post-closing claims for undisclosed issues.
Sellers have incentives to limit the scope of due diligence and to restrict access to sensitive information. Buyers seek broad access to books and records, key personnel interviews, and third-party verification. The tension between these interests shapes the information available to both parties at closing and affects how courts later interpret what each party knew or should have known about disclosed and undisclosed risks.
Escrow Arrangements and Post-Closing Dispute Resolution
Purchase agreements often require the seller to place a portion of the purchase price in escrow, typically 10 to 20 percent, to secure indemnification obligations. The escrow agent holds the funds and releases them after the survival period expires or upon resolution of disputes. Escrow arrangements provide a practical mechanism for the buyer to recover indemnification claims without pursuing the seller directly.
In New York courts, escrow disputes often turn on whether the buyer provided timely notice of claims, whether the claimed breaches fall within the scope of representations, and whether the damages calculation is supported by evidence. Courts have held that escrow release provisions are enforceable contracts and will interpret them according to their plain language, though ambiguities may be resolved against the drafter.
4. Strategic Considerations for Deal Structuring and Timing
Deal structure, regulatory approval sequencing, and timing decisions made early in an M&A transaction have lasting consequences for risk allocation and execution risk. Corporate counsel should evaluate whether the transaction will be structured as a stock purchase, asset purchase, or merger; whether regulatory filings must precede or follow signing; and whether conditions to closing (such as regulatory approval or third-party consents) will be satisfied before or after the signing date.
Transactions structured as stock purchases typically preserve all liabilities with the target and require broader seller representations and indemnification. Asset purchases allow buyers to select which liabilities to assume, but require third-party consent and may trigger successor liability issues under state law. Merger structures offer tax efficiency but create continuity of liabilities and regulatory obligations for the surviving entity.
Regulatory approval timelines and conditions should be evaluated early. If antitrust review is likely, parties should consider whether to file Hart-Scott-Rodino early to allow time for a Second Request. If state or federal licenses or approvals are required, timing of applications and approval conditions should be negotiated in the purchase agreement to allocate responsibility and risk between buyer and seller. Understanding these procedural requirements allows counsel to structure the deal timeline realistically and to identify potential deal-breakers before substantial resources are invested.
From a corporate governance perspective, boards should ensure that deal evaluation is documented contemporaneously, that independent advisors are engaged early, and that conflicts of interest are managed transparently. Consider whether administrative legal services may be needed to navigate regulatory approvals, and whether financial services law expertise is required if the target operates in regulated sectors. These early decisions about process, timing, and advisor engagement create the foundation for post-closing credibility if transaction terms or outcomes are later challenged by shareholders or regulators.
22 Apr, 2026
